DXC-007

N/A

Report date: 2025/02/13 16:05:21

Base Information

Drug NameDXC-007
Drug Alias NameDXC-007
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > Disulfide bond linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Tub255 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Myeloid cell surface antigen CD33Tubulin inhibitors
TargetsMyeloid cell surface antigen CD33Tubulin
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHangzhou Dac Biotech Company Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou Dac Biotech Company Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, AcuteLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A